Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 12.63%
March 31, 2026 19.60%
December 31, 2025 10.01%
September 30, 2025 15.28%
June 30, 2025 14.94%
March 31, 2025 20.14%
December 31, 2024 11.90%
September 30, 2024 14.43%
June 30, 2024 13.81%
March 31, 2024 21.08%
December 31, 2023 13.12%
September 30, 2023 17.15%
June 30, 2023 16.72%
March 31, 2023 22.18%
December 31, 2022 13.92%
September 30, 2022 16.62%
June 30, 2022 16.07%
March 31, 2022 22.49%
December 31, 2021 14.30%
September 30, 2021 17.85%
June 30, 2021 17.69%
March 31, 2021 21.42%
December 31, 2020 7.76%
September 30, 2020 17.67%
June 30, 2020 15.85%
Date Value
March 31, 2020 20.85%
December 31, 2019 12.22%
September 30, 2019 19.48%
June 30, 2019 18.24%
March 31, 2019 23.94%
December 31, 2018 18.74%
September 30, 2018 18.08%
June 30, 2018 25.84%
March 31, 2018 37.31%
December 31, 2017 39.33%
September 30, 2017 34.94%
June 30, 2017 34.63%
March 31, 2017 38.31%
December 31, 2016 18.10%
September 30, 2016 32.07%
June 30, 2016 35.16%
March 31, 2016 37.98%
December 31, 2015 34.40%
September 30, 2015 34.46%
June 30, 2015 37.30%
March 31, 2015 34.32%
December 31, 2014 33.01%
September 30, 2014 33.32%
June 30, 2014 34.94%
March 31, 2014 33.01%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sinopharm Group Co., Ltd. --
PomDoctor Ltd. --
Cencora, Inc. 3.93%
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%